Analysis/NN
of/IN
Gene/NN
Expression/NN
in/IN
Cyclooxygenase-2-Overexpressed/JJ
Human/JJ
Osteosarcoma/NN
Cell/NN
Lines/NNS
./.
====================
Osteosarcoma/NN
is/VBZ
the/DT
most/JJS
common/JJ
primary/JJ
bone/NN
tumor/NN
,/,
generally/RB
affecting/VBG
young/JJ
people/NN
./.
====================
While/IN
the/DT
etiology/NN
of/IN
osteosarcoma/NN
has/VBZ
been/VBN
largely/RB
unknown/JJ
,/,
recent/JJ
studies/NNS
have/VBP
suggested/VBN
that/IN
cyclooxygenase-2/NN
(/(
COX-2/NN
)/)
plays/VBZ
a/DT
critical/JJ
role/NN
in/IN
the/DT
proliferation/NN
,/,
migration/NN
,/,
and/CC
invasion/NN
of/IN
osteosarcoma/NN
cells/NNS
./.
====================
To/TO
understand/VB
the/DT
mechanism/NN
of/IN
action/NN
of/IN
COX-2/NN
in/IN
the/DT
pathogenesis/NN
of/IN
osteosarcoma/NN
,/,
we/PRP
compared/VBD
gene/NN
expression/NN
patterns/NNS
between/IN
three/CD
stable/JJ
COX-2-overexpressing/JJ
cell/NN
lines/NNS
and/CC
three/CD
control/JJ
cell/NN
lines/NNS
derived/VBN
from/IN
U2OS/NN
human/JJ
osteosarcoma/NN
cells/NNS
./.
====================
The/DT
data/NNS
showed/VBD
that/IN
56/CD
genes/NNS
were/VBD
upregulated/VBN
,/,
whereas/IN
20/CD
genes/NNS
were/VBD
downregulated/VBN
,/,
in/IN
COX-2-overexpressed/JJ
cell/NN
lines/NNS
,/,
with/IN
an/DT
average/NN
fold-change/NN
>/JJR
1.5/CD
./.
====================
Among/IN
the/DT
upregulated/VBN
genes/NNS
,/,
COL1A1/NN
,/,
COL5A2/NN
,/,
FBN1/NN
,/,
HOXD10/NN
,/,
RUNX2/NN
,/,
and/CC
TRAPPC2are/JJ
involved/VBN
in/IN
bone/NN
and/CC
skeletal/JJ
system/NN
development/NN
,/,
while/IN
DDR2/NN
,/,
RAC2/NN
,/,
RUNX2/NN
,/,
and/CC
TSPAN31are/NN
involved/VBN
in/IN
the/DT
positive/JJ
regulation/NN
of/IN
cell/NN
proliferation/NN
./.
====================
Among/IN
the/DT
downregulated/JJ
genes/NNS
,/,
HIST1H1D/NN
,/,
HIST1H2AI/NN
,/,
HIST1H3H/NN
,/,
and/CC
HIST1H4C/NN
are/VBP
involved/VBN
in/IN
nucleosome/JJ
assembly/NN
and/CC
DNA/NN
packaging/NN
./.
====================
These/DT
results/NNS
may/MD
provide/VB
useful/JJ
information/NN
to/TO
elucidate/VB
the/DT
molecular/JJ
mechanism/NN
of/IN
the/DT
COX-2-mediated/JJ
malignant/JJ
phenotype/NN
in/IN
osteosarcoma/NN
./.
====================
Osteosarcoma/NN
is/VBZ
the/DT
most/JJS
common/JJ
primary/JJ
bone/NN
tumor/NN
,/,
representing/VBG
over/IN
56/CD
%/NN
of/IN
all/DT
bone/NN
tumors/NNS
./.
====================
It/PRP
generally/RB
affects/VBZ
young/JJ
people/JJ
with/IN
the/DT
age/NN
of/IN
15/CD
to/TO
19/CD
and/CC
usually/RB
occurs/VBZ
in/IN
long/JJ
bones/NNS
near/JJ
the/DT
metaphyseal/JJ
growth/NN
plates/VBZ
./.
====================
It/PRP
has/VBZ
a/DT
high/JJ
tendency/NN
to/TO
metastasize/VB
,/,
and/CC
about/RB
10/CD
%/NN
-20/CD
%/NN
of/IN
patients/NNS
have/VBP
macroscopic/JJ
evidence/NN
of/IN
metastasis/NN
at/IN
the/DT
time/NN
of/IN
diagnosis/NN
,/,
while/IN
80/CD
%/NN
-90/CD
%/NN
of/IN
patients/NNS
are/VBP
assumed/VBN
to/TO
have/VB
micrometastasis/NNS
./.
====================
Although/IN
it/PRP
has/VBZ
been/VBN
postulated/VBN
that/IN
rapid/JJ
bone/NN
growth/NN
,/,
exposure/NN
to/TO
radiation/NN
,/,
and/CC
genetic/JJ
predispositions/NNS
,/,
such/JJ
as/IN
RB/NN
or/CC
p53/NN
mutations/NNS
,/,
are/VBP
thought/VBN
to/TO
be/VB
risk/NN
factors/NNS
for/IN
developing/VBG
osteosarcoma/NN
,/,
the/DT
etiology/NN
has/VBZ
not/RB
been/VBN
fully/RB
understood/VBN
[/(
1/CD
,/,
2/CD
,/,
3/CD
]/)
./.
====================
Prostaglandin/NN
endoperoxide/NN
synthase/NN
2/CD
(/(
PTGS2/NN
)/)
,/,
also/RB
called/VBN
as/IN
cyclooxygenase-2/NN
(/(
COX-2/NN
)/)
,/,
catalyzes/VBZ
the/DT
convertsion/NN
of/IN
arachidonic/JJ
acid/NN
to/TO
prostaglandin/NN
H2/NN
,/,
from/IN
which/WDT
various/JJ
prostanoids/NNS
,/,
including/VBG
prostaglandin/NN
E2/NN
,/,
are/VBP
produced/VBN
[/(
4/CD
]/)
./.
====================
Accumulating/VBG
evidence/NN
indicates/VBZ
that/IN
COX-2/NN
is/VBZ
involved/VBN
in/IN
osteosarcoma/NN
development/NN
and/CC
progression/NN
./.
====================
Several/JJ
studies/NNS
have/VBP
reported/VBN
that/IN
high/JJ
levels/NNS
of/IN
COX-2/NN
expression/NN
is/VBZ
associated/VBN
with/IN
advanced/JJ
clinical/JJ
stage/NN
and/CC
metastasis/NN
[/(
5/CD
,/,
6/CD
]/)
,/,
as/IN
well/RB
as/IN
with/IN
lower/JJR
overall/JJ
survival/NN
rates/NNS
and/CC
disease-free/JJ
survival/NN
rates/NNS
[/(
7/CD
,/,
8/CD
,/,
9/CD
]/)
./.
====================
In/IN
addition/NN
,/,
COX-2/NN
inhibition/NN
by/IN
using/VBG
RNAi/JJ
or/CC
antisense/JJ
oligonucleotide/NN
inhibits/VBZ
cell/NN
proliferation/NN
and/CC
invasion/NN
in/IN
human/JJ
osteosarcoma/NN
cells/NNS
[/(
10/CD
,/,
11/CD
]/)
./.
====================
Also/RB
,/,
selective/JJ
COX-2/NN
inhibitors/NNS
reduce/VBP
not/RB
only/RB
osteosarcoma/NN
cell/NN
proliferation/NN
and/CC
invasion/NN
in/IN
vitro/FW
but/CC
also/RB
tumor/NN
growth/NN
and/CC
metastasis/NN
in/IN
vivo/FW
[/(
12/CD
,/,
13/CD
]/)
./.
====================
Moreover/RB
,/,
we/PRP
have/VBP
previously/RB
reported/VBD
that/IN
COX-2/NN
overexpression/NN
promotes/VBZ
cell/NN
proliferation/NN
,/,
migration/NN
,/,
and/CC
invasion/NN
in/IN
U2OS/NN
human/JJ
osteosarcoma/NN
cells/NNS
[/(
14/CD
]/)
./.
====================
These/DT
studies/NNS
strongly/RB
suggest/VBP
that/IN
COX-2/NN
might/MD
be/VB
a/DT
causal/JJ
factor/NN
for/IN
the/DT
development/NN
and/CC
progression/NN
of/IN
osteosarcoma/NN
./.
====================
However/RB
,/,
the/DT
exact/JJ
mechanisms/NNS
of/IN
action/NN
of/IN
COX-2/NN
in/IN
osteosarcoma/NN
are/VBP
largely/RB
unknown/JJ
./.
====================
In/IN
an/DT
attempt/NN
to/TO
figure/NN
out/IN
the/DT
mechanism/NN
of/IN
action/NN
of/IN
COX-2/NN
in/IN
osteosarcoma/NN
,/,
we/PRP
analyzed/VBD
the/DT
gene/NN
expression/NN
profiles/NNS
in/IN
three/CD
COX-2-overexpressed/JJ
U2OS/NN
stable/JJ
cell/NN
lines/NNS
and/CC
three/CD
control/JJ
stable/JJ
cell/NN
lines/NNS
./.
====================
Establishment/JJ
and/CC
maintenance/NN
of/IN
stable/JJ
cell/NN
lines/NNS
====================
Human/JJ
COX-2/NN
cDNA/NN
was/VBD
subcloned/VBN
into/IN
the/DT
pcDNA3/NN
vector/NN
containing/VBG
neor/JJ
./.
====================
U2OS/NNS
cells/NNS
were/VBD
transfected/VBN
with/IN
COX-2/NN
or/CC
pcDNA3/NN
DNA/NN
using/VBG
Lipofectamine2000/NN
(/(
Life/NN
Technologies/NNS
,/,
Grand/NN
Island/CC
,/,
NY/NN
,/,
USA/NN
)/)
./.
====================
Transfectants/NNS
were/VBD
selected/VBN
in/IN
the/DT
presence/NN
of/IN
geneticin/NN
,/,
and/CC
individual/JJ
clones/NNS
were/VBD
maintained/VBN
in/IN
Dulbecco/NN
's/POS
modified/VBN
Eagle/JJ
's/POS
medium/NN
,/,
containing/VBG
fetal/JJ
bovine/NN
serum/NN
(/(
10/CD
%/NN
)/)
,/,
penicillin/NN
(/(
100/CD
units/mL/NN
)/)
,/,
streptomycin/NN
(/(
100/CD
units/mL/NN
)/)
,/,
and/CC
geneticin/NN
(/(
700/CD
µg/mL/NNS
)/)
,/,
as/IN
reported/VBN
previously/RB
[/(
14/CD
]/)
./.
====================
RNA/NN
isolation/NN
====================
Total/JJ
RNA/NN
was/VBD
extracted/VBN
from/IN
cells/NNS
with/IN
Trizol/NN
(/(
Life/NN
Technologies/NNS
)/)
,/,
purified/VBN
with/IN
the/DT
addition/NN
of/IN
chloroform/NN
,/,
and/CC
precipitated/VBD
with/IN
the/DT
addition/NN
of/IN
isopropanol/NN
./.
====================
The/DT
RNA/NN
concentration/NN
was/VBD
determined/VBN
by/IN
a/DT
spectrophotometer/JJ
,/,
and/CC
the/DT
quality/NN
of/IN
RNA/NN
was/VBD
evaluated/VBN
by/IN
the/DT
OD/NN
260/280/CD
ratio/NN
and/CC
gel/NN
electrophoresis/NN
./.
====================
Hybridization/NN
to/TO
expression/NN
arrays/NNS
====================
The/DT
following/VBG
procedures/NNS
were/VBD
carried/VBN
out/RP
by/IN
Macrogen/NN
Co./NN
(/(
Seoul/JJ
,/,
Korea/NN
)/)
./.
====================
First/RB
,/,
total/JJ
RNA/NN
was/VBD
amplified/VBN
and/CC
purified/VBN
using/VBG
the/DT
Ambion/NN
Illumina/NN
RNA/NN
amplification/NN
kit/NN
to/TO
yield/VB
biotinylated/VBN
cRNA/NN
(/(
Ambion/NN
,/,
Austin/NN
,/,
TX/NN
,/,
USA/NN
)/)
./.
====================
Briefly/RB
,/,
550/CD
ng/NN
of/IN
total/JJ
RNA/NN
was/VBD
reverse-transcribed/VBN
to/TO
cDNA/NN
using/VBG
a/DT
T7/NN
oligo/JJ
(/(
dT/NN
)/)
primer/NN
./.
====================
Second-strand/CC
cDNA/NN
was/VBD
synthesized/VBN
,/,
in/IN
vitro-transcribed/JJ
,/,
and/CC
labeled/VBN
with/IN
biotin-NTP/NN
./.
====================
After/IN
purification/NN
,/,
750/CD
ng/NN
of/IN
labeled/VBN
cRNA/NN
was/VBD
hybridized/VBN
to/TO
the/DT
humanHT-12/NN
expression/NN
v.4/CD
bead/RB
array/NN
(/(
Illumina/NN
,/,
San/NNP
Diego/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
for/IN
16-18/CD
h/NN
at/IN
58℃/CD
./.
====================
The/DT
array/NN
signal/NN
was/VBD
detected/VBN
using/VBG
Amersham/JJ
fluorolink/NN
streptavidin-Cy3/NN
(/(
GE/NN
Healthcare/JJ
Bio-Sciences/NNS
,/,
Little/JJ
Chalfont/JJ
,/,
UK/NN
)/)
./.
====================
Arrays/NNS
were/VBD
scanned/VBN
with/IN
an/DT
Illumina/NN
bead/VBD
array/NN
reader/confocal/JJ
scanner/NN
./.
====================
Array/NN
data/NNS
were/VBD
filtered/VBN
by/IN
a/DT
detection/NN
p-value/NN
</JJR
0.05/CD
(/(
similar/JJ
to/TO
signal/VB
to/TO
noise/JJ
)/)
./.
====================
Selected/VBN
gene/NN
signal/NN
values/NNS
were/VBD
log-transformed/VBN
and/CC
normalized/VBD
by/IN
the/DT
quantile/JJ
method/NN
./.
====================
Statistical/JJ
analysis/NN
====================
Basic/JJ
statistical/JJ
analyses/NNS
were/VBD
performed/VBN
using/VBG
Microsoft/JJ
Excel/JJ
./.
====================
Hierarchical/JJ
cluster/NN
analysis/NN
was/VBD
conducted/VBN
with/IN
normalized/VBN
log2-gene/NN
expression/NN
values/NNS
using/VBG
Cluster/NN
3.0/CD
,/,
and/CC
the/DT
results/NNS
were/VBD
visualized/VBN
using/VBG
Java/NN
Treeview/NN
[/(
15/CD
,/,
16/CD
]/)
./.
====================
An/DT
unrooted/JJ
tree/CD
was/VBD
drawn/VBN
with/IN
R/NN
package/NN
./.
====================
Biological/JJ
function/NN
analysis/NN
was/VBD
performed/VBN
with/IN
official/JJ
gene/NN
names/NNS
using/VBG
DAVID/NN
(/(
http/NN
:/:
//david.abcc.ncifcrf.gov//JJ
)/)
./.
====================
Stable/JJ
cell/NN
lines/NNS
====================
We/PRP
have/VBP
previously/RB
established/VBN
stable/JJ
cell/NN
lines/NNS
over-expressing/VBG
human/JJ
COX-2/NN
in/IN
U2OS/NN
human/JJ
osteosarcoma/NN
cells/NNS
./.
====================
To/TO
avoid/VB
clonal/JJ
variations/NNS
,/,
we/PRP
established/VBD
three/CD
stable/JJ
COX-2-overexpressing/JJ
cell/NN
lines/NNS
(/(
U2OS-COX-2/NN
#/CD
1/CD
,/,
#/NNP
2/CD
,/,
and/CC
#/FW
3/CD
)/)
and/CC
three/CD
control/JJ
cell/NN
lines/NNS
(/(
U2OS-pcDNA3/NN
#/CD
1/CD
,/,
#/NNP
2/CD
,/,
and/CC
#/FW
3/CD
)/)
./.
====================
High/JJ
levels/NNS
of/IN
COX-2/NN
expression/NN
were/VBD
observed/VBN
by/IN
western/NN
blot/NN
analysis/NN
in/IN
U2OS-COX-2/NN
cells/NNS
,/,
whereas/IN
the/DT
expression/NN
was/VBD
barely/RB
detectable/JJ
in/IN
U2OS-pcDNA3/NN
cells/NNS
./.
====================
When/WRB
we/PRP
cultured/VBD
the/DT
stable/JJ
cell/NN
lines/NNS
,/,
we/PRP
observed/VBD
that/IN
cell/NN
proliferation/NN
,/,
migration/NN
,/,
and/CC
invasion/NN
rates/NNS
were/VBD
increased/VBN
significantly/RB
in/IN
U2OS-COX-2/NN
cells/NNS
as/IN
compared/VBN
with/IN
U2OS-pcDNA3/NN
cells/NNS
[/(
14/CD
]/)
(/(
Table/JJ
1/CD
)/)
./.
====================
Gene/NN
expression/NN
====================
We/PRP
first/RB
performed/VBN
unsupervised/JJ
cluster/NN
analysis/NN
comparing/VBG
COX-2-overexpressing/JJ
cell/NN
lines/NNS
and/CC
control/NN
cell/NN
lines/NNS
./.
====================
Among/IN
24,371/CD
probe/NN
sets/NNS
,/,
we/PRP
selected/VBD
and/CC
analyzed/VBD
567/CD
probe/NN
sets/NNS
with/IN
a/DT
standard/JJ
deviation/NN
>/JJR
0.5/CD
./.
====================
The/DT
group/NN
of/IN
U2OS-COX-2/NN
(/(
U2OS-COX-2/NN
#/CD
1/CD
,/,
#/NNP
2/CD
,/,
and/CC
#/FW
3/CD
)/)
and/CC
the/DT
group/NN
of/IN
U2OS-pcDNA3/NN
(/(
U2OS-pcDNA3/NN
#/CD
1/CD
,/,
#/NNP
2/CD
,/,
and/CC
#/FW
3/CD
)/)
were/VBD
well/RB
segregated/VBD
in/IN
the/DT
unsupervised/JJ
cluster/NN
analysis/NN
,/,
confirming/VBG
that/IN
our/PRP$
experiment/NN
was/VBD
validated/VBN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
To/TO
identify/VB
significantly/RB
differentially/RB
expressed/VBN
genes/NNS
(/(
DEGs/NNS
)/)
in/IN
COX-2-overexpressing/JJ
osteosarcoma/NN
cells/NNS
,/,
we/PRP
first/RB
performed/VBN
the/DT
Wilcoxon/JJ
rank/VBP
sum/NN
test/NN
between/IN
the/DT
group/NN
of/IN
U2OS-COX-2/NN
and/CC
the/DT
group/NN
of/IN
U2OS-pcDNA3/NN
./.
====================
The/DT
2,144/CD
probe/NN
sets/NNS
passed/VBN
the/DT
criteria/NNS
./.
====================
Then/RB
,/,
to/TO
identify/VB
DEGs/NNS
,/,
we/PRP
selected/VBD
76/CD
probe/NN
sets/NNS
with/IN
an/DT
average/NN
fold-change/NN
>/JJR
1.5/CD
./.
====================
Among/IN
the/DT
DEGs/NNS
,/,
56/CD
genes/NNS
were/VBD
upregulated/VBN
while/IN
20/CD
genes/NNS
were/VBD
downregulated/VBN
in/IN
the/DT
group/NN
of/IN
U2OS-COX-2/NN
as/IN
compared/VBN
to/TO
the/DT
group/NN
of/IN
U2OS-pcDNA3/NN
(/(
Tables/NNS
2/CD
and/CC
3/CD
)/)
./.
====================
The/DT
heat/NN
map/VBP
of/IN
DEGs/NNS
is/VBZ
provided/VBN
in/IN
Fig/NN
./.
====================
2/CD
./.
====================
The/DT
gene/NN
encoding/VBG
COX-2/NN
,/,
PTGS2/NN
,/,
was/VBD
upregulated/VBN
by/IN
10.41-fold/JJ
in/IN
the/DT
COX-2-overexpressing/JJ
cell/NN
lines/NNS
as/IN
compared/VBN
to/TO
the/DT
control/NN
cell/NN
lines/NNS
,/,
confirming/VBG
again/RB
that/DT
our/PRP$
experiment/NN
is/VBZ
validated/VBN
(/(
Table/JJ
2/CD
)/)
./.
====================
Functional/JJ
analysis/NN
====================
The/DT
DEGs/NNS
were/VBD
concentrated/VBN
in/IN
several/JJ
important/JJ
biological/JJ
functions/NNS
====================
The/DT
functions/NNS
that/IN
were/VBD
most/RBS
significantly/RB
upregulated/VBN
by/IN
COX-2/NN
overexpression/NN
in/IN
U2OS/NN
cells/NNS
were/VBD
skeletal/JJ
system/NN
development/NN
and/CC
morphogenesis/NN
,/,
bone/NN
development/NN
and/CC
morphogenesis/NN
,/,
ossification/NN
,/,
and/CC
positive/JJ
regulation/NN
of/IN
cell/NN
proliferation/NN
(/(
p/NN
</JJR
0.05/CD
)/)
(/(
Table/JJ
4/CD
)/)
./.
====================
The/DT
genes/NNS
of/IN
COL1A1/NN
,/,
COL5A2/NN
,/,
FBN1/NN
,/,
HOXD10/NN
,/,
RUNX2/NN
,/,
and/CC
TRAPPC2/NN
are/VBP
involved/VBN
in/IN
skeletal/JJ
system/NN
development/NN
and/CC
morphogenesis/NN
./.
====================
The/DT
genes/NNS
of/IN
COL1A1/NN
,/,
COL5A2/NN
,/,
and/CC
RUNX2/NN
are/VBP
involved/VBN
in/IN
bone/NN
development/NN
,/,
morphogenesis/NN
and/CC
ossification/NN
./.
====================
The/DT
genes/NNS
of/IN
DDR2/NN
,/,
RAC2/NN
,/,
RUNX2/NN
,/,
and/CC
TSPAN31/NN
are/VBP
involved/VBN
in/IN
the/DT
positive/JJ
regulation/NN
of/IN
cell/NN
proliferation/NN
(/(
Table/JJ
4/CD
)/)
./.
====================
The/DT
functions/NNS
that/IN
were/VBD
most/RBS
significantly/RB
downregulated/VBD
by/IN
COX-2/NN
overexpression/NN
in/IN
U2OS/NN
cells/NNS
were/VBD
nucleosome/JJ
assembly/NN
,/,
chromatin/NN
assembly/NN
,/,
and/CC
DNA/NN
packaging/NN
(/(
p/NN
</JJR
0.05/CD
)/)
./.
====================
The/DT
genes/NNS
of/IN
HIST1H1D/NN
,/,
HIST1H2AI/NN
,/,
HIST1H3H/NN
,/,
and/CC
HIST1H4C/NN
are/VBP
involved/VBN
in/IN
these/DT
processes/NNS
(/(
Table/JJ
5/CD
)/)
./.
====================
COX-2/NN
has/VBZ
been/VBN
reported/VBN
to/TO
promote/VB
cell/NN
proliferation/NN
,/,
migration/NN
,/,
and/CC
invasion/NN
in/IN
osteosarcoma/NN
cells/NNS
./.
====================
COX-2/NN
gene/NN
knockdown/VBN
by/IN
RNAi/NN
significantly/RB
reduced/VBD
the/DT
cell/NN
proliferation/NN
,/,
migration/NN
,/,
and/CC
invasion/NN
in/IN
SaOS2/NN
cells/NNS
[/(
11/CD
]/)
,/,
whereas/IN
stable/JJ
expression/NN
of/IN
COX-2/NN
increased/VBD
the/DT
ability/NN
in/IN
U2OS/NN
cells/NNS
[/(
14/CD
]/)
(/(
Table/JJ
1/CD
)/)
./.
====================
These/DT
studies/NNS
demonstrated/VBD
that/IN
abnormal/JJ
COX-2/NN
overexpression/NN
is/VBZ
an/DT
important/JJ
determinant/NN
for/IN
the/DT
malignant/JJ
phenotype/NN
of/IN
osteosarcoma/NN
cells/NNS
./.
====================
By/IN
using/VBG
bioinformatics/NNS
tools/NNS
,/,
we/PRP
here/RB
provided/VBD
useful/JJ
information/NN
to/TO
understand/VB
the/DT
underlying/VBG
mechanism/NN
by/IN
which/WDT
COX-2/NN
promotes/VBZ
the/DT
malignant/JJ
phenotype/NN
in/IN
osteosarcoma/NN
cells/NNS
./.
====================
According/VBG
to/TO
our/PRP$
data/NNS
,/,
the/DT
genes/NNS
encoding/VBG
extracellular/JJ
matrix/NN
proteins/NNS
are/VBP
highly/RB
upregulated/VBN
by/IN
COX-2/NN
(/(
Tables/NNS
2/CD
and/CC
4/CD
)/)
./.
====================
The/DT
genes/NNS
COL1A1/NN
,/,
COL5A2/NN
,/,
and/CC
FBN1/NN
encode/VBP
α1/NN
chain/NN
of/IN
type/NN
I/CD
collagen/NN
,/,
α2/NN
chain/NN
of/IN
type/NN
V/JJ
collagen/NN
,/,
and/CC
fibrillin/NN
1/CD
,/,
respectively/RB
./.
====================
It/PRP
has/VBZ
been/VBN
known/VBN
that/IN
the/DT
type/NN
I/CD
and/CC
type/NN
V/JJ
collagens/NNS
are/VBP
major/JJ
extracellular/JJ
matrix/NN
proteins/NNS
in/IN
bone/NN
[/(
17/CD
]/)
./.
====================
Although/IN
there/EX
is/VBZ
a/DT
report/NN
that/IN
type/NN
I/CD
collagen/NN
promotes/VBZ
cell/NN
proliferation/NN
and/CC
migration/NN
in/IN
gastric/JJ
cancer/NN
cells/NNS
[/(
18/CD
]/)
,/,
the/DT
causal/JJ
relationship/NN
between/IN
the/DT
overexpression/NN
of/IN
those/DT
genes/NNS
and/CC
osteosarcoma/NN
has/VBZ
not/RB
been/VBN
investigated/VBN
well/RB
./.
====================
Therefore/RB
,/,
further/RB
studies/NNS
are/VBP
necessary/JJ
to/TO
elucidate/VB
whether/IN
overexpression/NN
of/IN
these/DT
genes/NNS
might/MD
be/VB
involved/VBN
in/IN
the/DT
COX-2-mediated/JJ
malignant/JJ
phenotype/NN
in/IN
osteosarcoma/NN
./.
====================
Extracellular/JJ
matrix/NN
proteins/NNS
not/RB
only/RB
are/VBP
structural/JJ
components/NNS
of/IN
the/DT
connective/JJ
tissue/NN
in/IN
the/DT
body/NN
but/CC
also/RB
regulate/VBP
cell/NN
fates/NNS
through/IN
their/PRP$
receptors/NNS
on/IN
the/DT
cell/NN
surface/NN
./.
====================
DDR2/NN
is/VBZ
one/CD
of/IN
the/DT
receptors/NNS
for/IN
collagen/NN
,/,
the/DT
expression/NN
of/IN
which/WDT
was/VBD
highly/RB
upregulated/VBN
by/IN
COX-2/NN
(/(
Tables/NNS
2/CD
and/CC
4/CD
)/)
./.
====================
DDR2/NN
is/VBZ
a/DT
receptor/NN
tyrosine/NN
kinase/NN
,/,
and/CC
its/PRP$
overexpression/NN
promotes/VBZ
the/DT
migration/NN
and/CC
invasion/NN
of/IN
cancer/NN
cells/NNS
derived/VBN
from/IN
breast/NN
,/,
head/RB
and/CC
neck/NN
,/,
and/CC
prostate/NN
[/(
19/CD
,/,
20/CD
,/,
21/CD
]/)
./.
====================
Therefore/RB
,/,
COX-2/NN
might/MD
promote/VB
cell/NN
proliferation/NN
and/CC
motility/NN
through/IN
upregulation/NN
of/IN
DDR2/NN
./.
====================
Further/RB
studies/NNS
are/VBP
necessary/JJ
to/TO
elucidate/VB
this/DT
possibility/NN
./.
====================
RAC2/NN
,/,
a/DT
highly/RB
upregulated/VBN
gene/NN
by/IN
COX-2/NN
,/,
is/VBZ
a/DT
member/NN
of/IN
the/DT
Rho/NN
family/NN
of/IN
GTPases/JJ
(/(
Tables/NNS
2/CD
and/CC
4/CD
)/)
./.
====================
Although/IN
there/EX
is/VBZ
no/DT
report/NN
on/IN
Rac2/NN
function/NN
in/IN
osteosarcoma/NN
,/,
there/EX
is/VBZ
a/DT
report/NN
that/IN
Rac2/NN
GTPase/NN
is/VBZ
required/VBN
for/IN
B/NN
cell/NN
proliferation/NN
and/CC
survival/NN
[/(
22/CD
]/)
./.
====================
Therefore/RB
,/,
COX-2/NN
might/MD
promote/VB
cell/NN
proliferation/NN
through/IN
upregulation/NN
of/IN
Rac2/NN
function/NN
./.
====================
Among/IN
the/DT
highly/RB
upregulated/VBN
genes/NNS
,/,
RUNX2/NN
encodes/VBZ
a/DT
transcription/NN
factor/NN
governing/VBG
osteoblast/JJ
differentiation/NN
and/CC
skeletal/JJ
morphogenesis/NN
./.
====================
Recent/JJ
studies/NNS
on/IN
Runx2/NN
function/NN
in/IN
cancer/NN
are/VBP
controversial/JJ
./.
====================
Runx2/NN
overexpression/NN
reduces/VBZ
cell/NN
proliferation/NN
in/IN
osteosarcoma/NN
cell/NN
lines/NNS
[/(
23/CD
]/)
but/CC
promotes/VBZ
cell/NN
motility/NN
or/CC
invasion/NN
in/IN
MCF-7/NN
breast/NN
cancer/NN
cells/NNS
and/CC
PC/NN
prostate/NN
cancer/NN
cells/NNS
[/(
24/CD
,/,
25/CD
]/)
./.
====================
Therefore/RB
,/,
further/RBR
studies/NNS
are/VBP
required/VBN
to/TO
elucidate/VB
the/DT
function/NN
of/IN
Runx2/NN
in/IN
osteosarcoma/NN
and/CC
the/DT
relation/NN
between/IN
COX-2/NN
and/CC
Runx2/NN
./.
====================
Intriguingly/RB
,/,
the/DT
genes/NNS
encoding/VBG
histone/NN
proteins/NNS
are/VBP
highly/RB
downregulated/VBD
by/IN
COX-2/NN
(/(
Tables/NNS
3/CD
and/CC
5/CD
)/)
./.
====================
The/DT
genes/NNS
HIST1H1D/NN
,/,
HIST1H2AI/NN
,/,
HIST1H3H/NN
,/,
and/CC
HIST1H4C/NN
encode/VBP
histone/NN
H1H1/NN
,/,
histone/NN
H2A1/NN
,/,
histone/NN
H3A1/NN
,/,
and/CC
histone/NN
H41/NN
,/,
respectively/RB
./.
====================
As/IN
is/VBZ
well/RB
known/VBN
,/,
the/DT
nucleosome/JJ
is/VBZ
the/DT
basic/JJ
unit/NN
of/IN
DNA/NN
packaging/NN
,/,
consisting/VBG
of/IN
a/DT
core/NN
particle/NN
and/CC
linker/NN
DNA/NN
./.
====================
A/DT
core/NN
particle/NN
comprises/VBZ
147/CD
base/NN
pairs/NNS
of/IN
DNA/NN
wrapped/VBD
around/IN
a/DT
histone/NN
octamer/NN
(/(
2/CD
copies/NNS
each/DT
of/IN
histone/NN
H2A/NN
,/,
H2B/NN
,/,
H3/NN
,/,
and/CC
H4/NN
)/)
./.
====================
The/DT
core/NN
particles/NNS
are/VBP
connected/VBN
by/IN
10-90/CD
bp/NN
of/IN
linker/NN
DNA/NN
,/,
which/WDT
could/MD
be/VB
naked/VBN
or/CC
bound/VBD
to/TO
histone/NN
H1/NN
[/(
26/CD
]/)
./.
====================
The/DT
nucleosome/JJ
itself/PRP
has/VBZ
been/VBN
known/VBN
to/TO
be/VB
a/DT
general/JJ
gene/NN
repressor/NN
[/(
27/CD
,/,
28/CD
]/)
./.
====================
In/IN
addition/NN
,/,
RNAi-mediated/JJ
knockdown/VBN
of/IN
H2A.Z/NN
reduced/VBD
cell/NN
proliferation/NN
in/IN
bladder/JJ
cancer/NN
cells/NNS
[/(
29/CD
]/)
./.
====================
These/DT
results/NNS
are/VBP
compatible/JJ
with/IN
our/PRP$
finding/NN
that/DT
COX-2/NN
downregulates/VBZ
the/DT
expression/NN
of/IN
histone/NN
genes/NNS
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
worth/NN
studying/VBG
the/DT
mechanism/NN
of/IN
action/NN
of/IN
histones/NNS
in/IN
osteosarcoma/NN
and/CC
the/DT
mechanism/NN
by/IN
which/WDT
COX-2/NN
downregulates/VBZ
histone/NN
genes/NNS
./.
====================
Osteosarcoma/NN
is/VBZ
a/DT
highly/RB
malignant/JJ
tumor/NN
,/,
and/CC
the/DT
5-year/JJ
survival/NN
rate/NN
is/VBZ
only/RB
20/CD
%/NN
-30/CD
%/NN
in/IN
patients/NNS
with/IN
macroscopic/JJ
evidence/NN
of/IN
metastasis/NN
at/IN
diagnosis/NN
[/(
3/CD
]/)
./.
====================
While/IN
the/DT
etiology/NN
of/IN
osteosarcoma/NN
has/VBZ
been/VBN
largely/RB
unknown/JJ
,/,
recent/JJ
studies/NNS
have/VBP
suggested/VBN
that/IN
COX-2/NN
plays/VBZ
a/DT
critical/JJ
role/NN
in/IN
osteosarcoma/NN
development/NN
and/CC
progression/NN
./.
====================
In/IN
this/DT
regard/NN
,/,
we/PRP
believe/VBP
that/IN
our/PRP$
study/NN
will/MD
provide/VB
useful/JJ
information/NN
to/TO
understand/VB
the/DT
mechanism/NN
of/IN
action/NN
of/IN
COX-2/NN
in/IN
osteosarcoma/NN
./.
====================
Segregation/NN
between/IN
the/DT
group/NN
of/IN
U2OS-COX-2/NN
and/CC
the/DT
group/NN
of/IN
U2OS-pcDNA3/NN
./.
====================
Unsupervised/JJ
cluster/NN
analysis/NN
was/VBD
done/VBN
between/IN
six/CD
stable/JJ
cell/NN
lines/NNS
using/VBG
567/CD
probe/NN
sets/NNS
with/IN
a/DT
standard/JJ
deviation/NN
>/JJR
0.5/CD
./.
====================
Normalized/VBN
log2-gene/NN
expression/NN
values/NNS
were/VBD
used/VBN
for/IN
hierarchical/JJ
clustering/NN
,/,
and/CC
an/DT
unrooted/JJ
tree/CD
was/VBD
drawn/VBN
by/IN
R/NN
package/NN
./.
====================
COX-2/NN
,/,
cyclooxygenase-2/NN
./.
====================
Gene/NN
expression/NN
patterns/NNS
of/IN
76/CD
differentially/RB
expressed/VBN
genes/NNS
(/(
DEGs/NNS
)/)
./.
====================
Hierarchical/JJ
cluster/NN
analysis/NN
was/VBD
done/VBN
between/IN
six/CD
stable/JJ
cell/NN
lines/NNS
using/VBG
76/CD
DEGs/NNS
./.
====================
Normalized/VBN
log2-gene/NN
expression/NN
values/NNS
were/VBD
analyzed/VBN
by/IN
Cluster/NN
3.0/CD
,/,
and/CC
the/DT
results/NNS
were/VBD
visualized/VBN
using/VBG
Java/NN
Treeview/NN
,/,
with/IN
red/JJ
being/VBG
high/JJ
and/CC
green/VBN
indicating/VBG
low/JJ
./.
====================
Summary/JJ
of/IN
stable/JJ
cell/NN
line/NN
characteristics/NNS
====================
Upregulated/JJ
DEGs/NNS
in/IN
COX-2-overexpressed/JJ
cell/NN
lines/NNS
====================
Downregulated/JJ
DEGs/NNS
in/IN
COX-2-overexpressed/JJ
cell/NN
lines/NNS
====================
Biological/JJ
functions/NNS
of/IN
upregulated/VBN
DEGs/NNS
====================
Biological/JJ
functions/NNS
of/IN
downregulated/JJ
DEGs/NNS
====================
